BioSpace News Archive

Cartilage regeneration is a kind of regenerative medicine technology used to restore damaged articular joint cartilage.

As COVID-19 activity continues in Canada, we are continuing to track key epidemiological indicators to monitor trends and quickly detect emerging issues of concern, including to better understand the impact of circulating virus variants.

AB Science SA (Euronext - FR0010557264 - AB) today announced that results from its Phase 3 AB09004 study on mild to moderate Alzheimer’s disease have been presented at the annual Alzheimer’s Association International Conference (AAIC) (July 26-30, 2021).

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Cristal N. Downing has been appointed chief communications & public affairs officer, a newly created role, effective August 16, 2021.

Lazarus 3D received its first 510(k) clearance from the Food and Drug Administration (FDA) for its patented PRE-SURE® technology. Lazarus 3D’s PRE-SURE® models are created in synthetic, soft-tissue materials that can be cut, sutured, and can even bleed.

Keystone Bio, a biotechnology company, is a frontrunner in developing precision biologics to eliminate Porphyromonas gingivalis (Pg), and is releasing groundbreaking data that shows bacterial toxic proteins from Pg in the mouth are released into the blood and cross the Blood Brain Barrier (BBB) as the major driver of sporadic Alzheimer’s and chronic inflammation.

At the Alzheimer’s Association International Conference® (AAIC®) 2021, in Denver and virtually, researchers shared new evidence-based insights into why people from communities of color do and do not choose to participate in clinical trials.

Sutro Biopharma, Inc. announced that Chief Executive Officer, Bill Newell, will participate in a panel titled “ADCs – Take Me to Your Tumor” at the 12th Annual Wedbush PacGrow Healthcare Virtual Conference on Wednesday, August 11, at 2:20 p.m. ET / 11:20 a.m. PT.

Blueprint Medicines Corporation reported financial results and provided a business update for the second quarter ended June 30, 2021.

Concert Pharmaceuticals, Inc. announced that it will report its financial results for the second quarter of 2021, on Thursday, August 5, 2021, before the U.S. financial markets open.